NOVEL STRATEGIES (FKA) PRISM GROUP

Lobbying for THE ALLIANCE FOR LONGEVITY INITIATIVES · Advancing policies to increase a healthy human lifespan.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $20,000.00 income · posted Jul 20, 2026

Lobbying activity 2

Health Issues

Directing the Food and Drug Administration to create a pathway for longevity treatment.

Budget/Appropriations

Increased funding for longevity research at the National Institutes of Health

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.